Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia
Abstract Bacillus anthracis, Yersinia pestis, and Francisella tularensis are the causative agents of Tier 1 Select Agents anthrax, plague, and tularemia, respectively. Currently, there are no licensed vaccines against plague and tularemia and the licensed anthrax vaccine is suboptimal. Here we repor...
Guardado en:
Autores principales: | Qingmei Jia, Richard Bowen, Barbara Jane Dillon, Saša Masleša-Galić, Brennan T. Chang, Austin C. Kaidi, Marcus A. Horwitz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/039eb01266304f9db9d89d2a778bed41 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters
por: Qingmei Jia, et al.
Publicado: (2021) -
Tularemia in the world
por: T. Yu. Kudryavtseva, et al.
Publicado: (2021) -
Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time
por: Bai-Yu Lee, et al.
Publicado: (2017) -
A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague
por: Pan Tao, et al.
Publicado: (2018) -
Anthrax lethal factor cleavage of Nlrp1 is required for activation of the inflammasome.
por: Jonathan L Levinsohn, et al.
Publicado: (2012)